Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes

Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johannes R. Graf, Stefan Forster, Frido K. Bruehl, Yara Banz, Mahmoud Hallal, Justine Brodard, Vera Ulrike Bacher, Ramanjaneyulu Allam, Christian M. Schürch, Nicolas Bonadies
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bf4a47d021b6457da642e660955cba02
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf4a47d021b6457da642e660955cba02
record_format dspace
spelling oai:doaj.org-article:bf4a47d021b6457da642e660955cba022021-11-25T17:03:00ZDiagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes10.3390/cancers132257122072-6694https://doaj.org/article/bf4a47d021b6457da642e660955cba022021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5712https://doaj.org/toc/2072-6694Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. Methods: We performed an exploratory, case-control study with 20 randomly selected MDS patients and nine controls with non-inflammatory (<i>n</i> = 3) and inflammatory conditions (<i>n</i> = 6). Patients were stratified in groups of lower (<i>n</i> = 10) and higher risk (<i>n</i> = 10) using IPSS-R. For the exploration of inflammasome and immune checkpoint activities, the expression of caspase-1 (Casp1), programmed cell death protein 1 (PD-1) and its ligand (PD-L1) were assessed in bone marrow samples using immunohistochemistry. Results: In multivariate analysis, we observed significant differences for Casp1 but not PD1/PD-L1 expression in our four conditions (<i>p</i> = 0.003). We found a discordant co-expression of Casp1/PD-L1 in MDS (rho = −0.41, <i>p</i> = 0.07) compared with a concordant co-expression in controls (rho = 0.64, <i>p</i> = 0.06). Neutrophil counts correlated directly with Casp1 (rho = 0.57, <i>p =</i> 0.009) but inversely with PD-L1 expression (rho = −0.58, <i>p</i> = 0.007). Conclusion: We identified characteristic discordant co-expression patterns in lower- (Casp1<sub>high</sub>/PD-L1<sub>low</sub>) and higher-risk MDS (Casp1<sub>low</sub>/PD-L1<sub>high</sub>), contrasting with concordant patterns in the non-inflammatory (Casp1<sub>low</sub>/PD-L1<sub>low</sub>) and inflammatory conditions (Casp1<sub>high</sub>/PD-L1<sub>high</sub>). Further validation is warranted in larger, prospective studies.Johannes R. GrafStefan ForsterFrido K. BruehlYara BanzMahmoud HallalJustine BrodardVera Ulrike BacherRamanjaneyulu AllamChristian M. SchürchNicolas BonadiesMDPI AGarticlemyelodysplastic syndromesinflammasomeimmune check-pointimmune-related biomarkersdiagnosisprognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5712, p 5712 (2021)
institution DOAJ
collection DOAJ
language EN
topic myelodysplastic syndromes
inflammasome
immune check-point
immune-related biomarkers
diagnosis
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle myelodysplastic syndromes
inflammasome
immune check-point
immune-related biomarkers
diagnosis
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Johannes R. Graf
Stefan Forster
Frido K. Bruehl
Yara Banz
Mahmoud Hallal
Justine Brodard
Vera Ulrike Bacher
Ramanjaneyulu Allam
Christian M. Schürch
Nicolas Bonadies
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
description Background: The inflammasome plays an essential role in lower risk MDS and immune subversion, with the up-regulation of immune checkpoint molecules in the progression to higher-risk disease. In this study, we explored the utility of immune-related biomarkers for the diagnosis and prognosis of MDS. Methods: We performed an exploratory, case-control study with 20 randomly selected MDS patients and nine controls with non-inflammatory (<i>n</i> = 3) and inflammatory conditions (<i>n</i> = 6). Patients were stratified in groups of lower (<i>n</i> = 10) and higher risk (<i>n</i> = 10) using IPSS-R. For the exploration of inflammasome and immune checkpoint activities, the expression of caspase-1 (Casp1), programmed cell death protein 1 (PD-1) and its ligand (PD-L1) were assessed in bone marrow samples using immunohistochemistry. Results: In multivariate analysis, we observed significant differences for Casp1 but not PD1/PD-L1 expression in our four conditions (<i>p</i> = 0.003). We found a discordant co-expression of Casp1/PD-L1 in MDS (rho = −0.41, <i>p</i> = 0.07) compared with a concordant co-expression in controls (rho = 0.64, <i>p</i> = 0.06). Neutrophil counts correlated directly with Casp1 (rho = 0.57, <i>p =</i> 0.009) but inversely with PD-L1 expression (rho = −0.58, <i>p</i> = 0.007). Conclusion: We identified characteristic discordant co-expression patterns in lower- (Casp1<sub>high</sub>/PD-L1<sub>low</sub>) and higher-risk MDS (Casp1<sub>low</sub>/PD-L1<sub>high</sub>), contrasting with concordant patterns in the non-inflammatory (Casp1<sub>low</sub>/PD-L1<sub>low</sub>) and inflammatory conditions (Casp1<sub>high</sub>/PD-L1<sub>high</sub>). Further validation is warranted in larger, prospective studies.
format article
author Johannes R. Graf
Stefan Forster
Frido K. Bruehl
Yara Banz
Mahmoud Hallal
Justine Brodard
Vera Ulrike Bacher
Ramanjaneyulu Allam
Christian M. Schürch
Nicolas Bonadies
author_facet Johannes R. Graf
Stefan Forster
Frido K. Bruehl
Yara Banz
Mahmoud Hallal
Justine Brodard
Vera Ulrike Bacher
Ramanjaneyulu Allam
Christian M. Schürch
Nicolas Bonadies
author_sort Johannes R. Graf
title Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
title_short Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
title_full Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
title_fullStr Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
title_full_unstemmed Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
title_sort diagnostic and prognostic implications of caspase-1 and pd-l1 co-expression patterns in myelodysplastic syndromes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bf4a47d021b6457da642e660955cba02
work_keys_str_mv AT johannesrgraf diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT stefanforster diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT fridokbruehl diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT yarabanz diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT mahmoudhallal diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT justinebrodard diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT veraulrikebacher diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT ramanjaneyuluallam diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT christianmschurch diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
AT nicolasbonadies diagnosticandprognosticimplicationsofcaspase1andpdl1coexpressionpatternsinmyelodysplasticsyndromes
_version_ 1718412800036962304